Stephen C Benson

Summary

Affiliation: California State University
Country: USA

Publications

  1. doi request reprint Inhibition of cardiovascular cell proliferation by angiotensin receptor blockers: are all molecules the same?
    Stephen C Benson
    Department of Biological Sciences, California State University, East Bay, Hayward, CA 94542, USA
    J Hypertens 26:973-80. 2008
  2. ncbi request reprint Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity
    Stephen C Benson
    Department of Biological Sciences, California State University, Hayward, USA
    Hypertension 43:993-1002. 2004
  3. ncbi request reprint Rosiglitazone inhibits proliferation, motility, and matrix metalloproteinase production in keratinocytes
    Narasimharao Bhagavathula
    Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA
    J Invest Dermatol 122:130-9. 2004
  4. ncbi request reprint Alpha-Lipoic acid-based PPARgamma agonists for treating inflammatory skin diseases
    Meenakshi S Venkatraman
    Department Medicinal Chemistry, University of Mississippi, University, MS, USA
    Arch Dermatol Res 296:97-104. 2004
  5. ncbi request reprint Inhibition of corneal neovascularization by a peroxisome proliferator-activated receptor-gamma ligand
    Melvin A Sarayba
    Department of Ophthalmology, University of California, 118 Med Surge I, Irvine, CA 92697 4375, USA
    Exp Eye Res 80:435-42. 2005
  6. ncbi request reprint Design and synthesis of the first generation of dithiolane thiazolidinedione- and phenylacetic acid-based PPARgamma agonists
    Amar G Chittiboyina
    Laboratory for Applied Drug Design and Synthesis, Department of Medicinal Chemistry, School of Pharmacy, University of Mississippi, 38677, USA
    J Med Chem 49:4072-84. 2006

Collaborators

  • T W Kurtz
  • Harrihar A Pershadsingh
  • M Pravenec
  • JAMES J VARANI
  • Mitchell A Avery
  • Christopher I Ho
  • Meenakshi S Venkatraman
  • Amar Chittiboyina
  • Amar G Chittiboyina
  • Melvin A Sarayba
  • Charles N Ellis
  • Narasimharao Bhagavathula
  • Cassia S Mizuno
  • Prashant V Desai
  • Akshay Patny
  • Kathryn E Osann
  • Norman H Liu
  • Anup J Patel
  • Roy S Chuck
  • Li Li
  • Paula M Sweet
  • Tulaya Tungsiripat
  • Josef Meingassner
  • Kamalakar C Nerusu
  • Ashish Lal

Detail Information

Publications6

  1. doi request reprint Inhibition of cardiovascular cell proliferation by angiotensin receptor blockers: are all molecules the same?
    Stephen C Benson
    Department of Biological Sciences, California State University, East Bay, Hayward, CA 94542, USA
    J Hypertens 26:973-80. 2008
    ..Few studies have directly compared the effects of different angiotensin receptor blockers (ARBs) on mechanisms involved in the pathogenesis of cardiovascular disease...
  2. ncbi request reprint Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity
    Stephen C Benson
    Department of Biological Sciences, California State University, Hayward, USA
    Hypertension 43:993-1002. 2004
    ....
  3. ncbi request reprint Rosiglitazone inhibits proliferation, motility, and matrix metalloproteinase production in keratinocytes
    Narasimharao Bhagavathula
    Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA
    J Invest Dermatol 122:130-9. 2004
    ....
  4. ncbi request reprint Alpha-Lipoic acid-based PPARgamma agonists for treating inflammatory skin diseases
    Meenakshi S Venkatraman
    Department Medicinal Chemistry, University of Mississippi, University, MS, USA
    Arch Dermatol Res 296:97-104. 2004
    ..These findings suggest that water-soluble lipoic acid-based thiazolidinediones may be efficacious as oral and topical agents for treating inflammatory skin conditions such as contact dermatitis, atopic dermatitis, and psoriasis...
  5. ncbi request reprint Inhibition of corneal neovascularization by a peroxisome proliferator-activated receptor-gamma ligand
    Melvin A Sarayba
    Department of Ophthalmology, University of California, 118 Med Surge I, Irvine, CA 92697 4375, USA
    Exp Eye Res 80:435-42. 2005
    ..To determine the efficacy of the peroxisome proliferator-activated receptor gamma agonist, pioglitazone, in inhibiting corneal neovascularization...
  6. ncbi request reprint Design and synthesis of the first generation of dithiolane thiazolidinedione- and phenylacetic acid-based PPARgamma agonists
    Amar G Chittiboyina
    Laboratory for Applied Drug Design and Synthesis, Department of Medicinal Chemistry, School of Pharmacy, University of Mississippi, 38677, USA
    J Med Chem 49:4072-84. 2006
    ..These novel compounds may prove efficacious not only in the treatment of Type 2 diabetes, but also atherosclerosis, prevention of vascular restenosis, and inflammatory skin diseases...